Based on 1 analyst offering 12 month price targets for Actinium Pharmaceuticals Inc
Min Forecast
$4.00+168.46%
Avg Forecast
$4.00+168.46%
Max Forecast
$4.00+168.46%
Should I buy or sell ATNM stock?
Based on 1 analyst offering ratings for Actinium Pharmaceuticals Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ATNM's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ATNM as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More
Be the first to know when Wall Street analysts revise their ATNM stock forecasts and price targets.
Is Actinium Pharmaceuticals Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSEMKT: ATNM) stock is to Buy ATNM stock.
Out of 1 analyst, 0 (0%) are recommending ATNM as a Strong Buy, 1 (100%) are recommending ATNM as a Buy, 0 (0%) are recommending ATNM as a Hold, 0 (0%) are recommending ATNM as a Sell, and 0 (0%) are recommending ATNM as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year ATNM price target, the average ATNM price target is $4.00, with the highest ATNM stock price forecast at $4.00 and the lowest ATNM stock price forecast at $4.00.
The Wall Street analyst predicted that Actinium Pharmaceuticals's share price could reach $4.00 by May 12, 2026. The average Actinium Pharmaceuticals stock price prediction forecasts a potential upside of 168.46% from the current ATNM share price of $1.49.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.